Company: IOBT
Filing Date: 2025-11-14
Form Type: 10-Q
Source: 0001193125-25-281820
Chunk: 1

Company: IO Biotech, Inc.
Filing Date: 2025-11-14
Form: 10-Q
Item: Item 1
Chunk 1
---
 September 30, 2025 and 65,880,914 shares issued and outstanding as of December 31, 2024.

     70

     66

     Additional paid-in capital

     424,335

     413,113

     Accumulated deficit

     (416,329
     )

     (359,313
     )

     Accumulated other comprehensive loss

     (7,165
     )

     (6,851
     )

     Total stockholders’ equity

     911

     47,015

     Total liabilities and stockholders’ equity
      
     $
     39,956

     $
     67,699

See accompanying notes to the unaudited interim consolidated financial statements.